These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29456879)

  • 21. Characteristic laryngoscopic findings in Parkinson's disease patients after subthalamic nucleus deep brain stimulation and its correlation with voice disorder.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
    J Neural Transm (Vienna); 2015 Dec; 122(12):1663-72. PubMed ID: 26254905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Tripoliti E; Strong L; Hickey F; Foltynie T; Zrinzo L; Candelario J; Hariz M; Limousin P
    Mov Disord; 2011 Nov; 26(13):2434-6. PubMed ID: 21953693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intelligibility of speech in Parkinson's disease relies on anatomically segregated subthalamic beta oscillations.
    Avantaggiato F; Farokhniaee A; Bandini A; Palmisano C; Hanafi I; Pezzoli G; Mazzoni A; Isaias IU
    Neurobiol Dis; 2023 Sep; 185():106239. PubMed ID: 37499882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subthalamic nucleus physiology is correlated with deep brain stimulation motor and non-motor outcomes.
    Levy M; Zurawel M; d'Hardemare V; Moran A; Andelman F; Manor Y; Cohen J; Meshulam M; Balash Y; Gurevich T; Fried I; Bergman H
    Brain Commun; 2023; 5(6):fcad268. PubMed ID: 38025270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subthalamic Stimulation Reduces Vowel Space at the Initiation of Sustained Production: Implications for Articulatory Motor Control in Parkinson's Disease.
    Sidtis JJ; Alken AG; Tagliati M; Alterman R; Van Lancker Sidtis D
    J Parkinsons Dis; 2016 Mar; 6(2):361-70. PubMed ID: 27003219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vocalic transitions as markers of speech acoustic changes with STN-DBS in Parkinson's Disease.
    Martel-Sauvageau V; Tjaden K
    J Commun Disord; 2017 Nov; 70():1-11. PubMed ID: 29032347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment.
    D'Alatri L; Paludetti G; Contarino MF; Galla S; Marchese MR; Bentivoglio AR
    J Voice; 2008 May; 22(3):365-72. PubMed ID: 17368837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Low versus High Frequency Subthalamic Deep Brain Stimulation on Speech Intelligibility and Verbal Fluency in Parkinson's Disease: A Double-Blind Study.
    Grover T; Georgiev D; Kalliola R; Mahlknecht P; Zacharia A; Candelario J; Hyam J; Zrinzo L; Hariz M; Foltynie T; Limousin P; Jahanshahi M; Tripoliti E
    J Parkinsons Dis; 2019; 9(1):141-151. PubMed ID: 30594934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in speech characters of patients with Parkinson's disease after bilateral subthalamic nucleus stimulation.
    Xie Y; Zhang Y; Zheng Z; Liu A; Wang X; Zhuang P; Li Y; Wang X
    J Voice; 2011 Nov; 25(6):751-8. PubMed ID: 21227642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay between speech and gait variables in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: A long-term instrumental assessment.
    Cavallieri F; Gessani A; Merlo A; Campanini I; Budriesi C; Fioravanti V; Di Rauso G; Feletti A; Damiano B; Scaltriti S; Guagnano N; Bardi E; Corni MG; Antonelli F; Cavalleri F; Molinari MA; Contardi S; Menozzi E; Puzzolante A; Vannozzi G; Bergamini E; Pavesi G; Fraix V; Meoni S; Fraternali A; Versari A; Lusuardi M; Biagini G; Pinto S; Moro E; Valzania F
    Eur J Neurol; 2023 Jul; 30(7):1963-1972. PubMed ID: 36971736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of speech rate modifications on phonatory acoustic outcomes in Parkinson's disease.
    Knowles T; Adams SG; Jog M
    Front Hum Neurosci; 2024; 18():1331816. PubMed ID: 38450224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Deep Brain Stimulation on Pausing During Spontaneous Speech in Parkinson's Disease.
    Ahn JS; Van Lancker Sidtis D; Sidtis JJ
    J Med Speech Lang Pathol; 2014; 21(3):179-186. PubMed ID: 26848252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dramatic effects of speech task on motor and linguistic planning in severely dysfluent parkinsonian speech.
    Van Lancker Sidtis D; Cameron K; Sidtis JJ
    Clin Linguist Phon; 2012 Aug; 26(8):695-711. PubMed ID: 22774929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's Disease.
    Pinto S; Nebel A; Rau J; Espesser R; Maillochon P; Niebuhr O; Krack P; Witjas T; Ghio A; Cuartero MC; Timmermann L; Schnitzler A; Hesekamp H; Meier N; Müllner J; Hälbig TD; Möller B; Paschen S; Paschen L; Volkmann J; Barbe MT; Fink GR; Becker J; Reker P; Kühn AA; Schneider GH; Fraix V; Seigneuret E; Kistner A; Rascol O; Brefel-Courbon C; Ory-Magne F; Hartmann CJ; Wojtecki L; Fradet A; Maltête D; Damier P; Le Dily S; Sixel-Döring F; Benecke P; Weiss D; Wächter T; Pinsker MO; Régis J; Thobois S; Polo G; Houeto JL; Hartmann A; Knudsen K; Vidailhet M; Schüpbach M; Deuschl G;
    Mov Disord; 2023 Feb; 38(2):212-222. PubMed ID: 36461899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatments for dysarthria in Parkinson's disease.
    Pinto S; Ozsancak C; Tripoliti E; Thobois S; Limousin-Dowsey P; Auzou P
    Lancet Neurol; 2004 Sep; 3(9):547-56. PubMed ID: 15324723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A preliminary report on disordered speech with deep brain stimulation in individuals with Parkinson's disease.
    Dromey C; Bjarnason S
    Parkinsons Dis; 2011; 2011():796205. PubMed ID: 22046577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of the pedunculopontine nucleus area in Parkinson's disease: effects on speech and intelligibility.
    Pinto S; Ferraye M; Espesser R; Fraix V; Maillet A; Guirchoum J; Layani-Zemour D; Ghio A; Chabardès S; Pollak P; Debû B
    Brain; 2014 Oct; 137(Pt 10):2759-72. PubMed ID: 25080284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perceived articulatory precision in patients with Parkinson's disease after deep brain stimulation of subthalamic nucleus and caudal zona incerta.
    Eklund E; Qvist J; Sandström L; Viklund F; Van Doorn J; Karlsson F
    Clin Linguist Phon; 2015 Feb; 29(2):150-66. PubMed ID: 25333411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal study of speech and dual-task performance in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation.
    Catalano Chiuvé S; Fournet M; Wegrzyk J; Assal F; Burkhard PR; Laganaro M
    Parkinsonism Relat Disord; 2022 Apr; 97():75-78. PubMed ID: 35349893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson's disease.
    Gessani A; Cavallieri F; Fioravanti V; Campanini I; Merlo A; Di Rauso G; Damiano B; Scaltriti S; Bardi E; Corni MG; Antonelli F; Cavalleri F; Molinari MA; Contardi S; Menozzi E; Fraternali A; Versari A; Biagini G; Fraix V; Pinto S; Moro E; Budriesi C; Valzania F
    Sci Rep; 2023 Jul; 13(1):11462. PubMed ID: 37454168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.